Effect of long-term treatment with propionyl-L-carnitine on smooth muscle cell polyploidy in spontaneously hypertensive rats

Hypertension

Volumn 28, Issue 2, 1996, Pages 177-182

  Mauriello, Alessandro ^a   Sangiorgi, Giuseppe ^b   Orlandi, Augusto ^a   Schiaroli, Stefania ^a   Perfumo, Sabina ^a   Spagnoli, Luigi Giusto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b MAYO CLINIC   (United States)

Author keywords

antihypertensive agents; polyploidy; propionyl L carnitine; rats, inbred SHR

Indexed keywords

CARNITINE DERIVATIVE;

ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; HYPERTENSION; MALE; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

EID: 0029763038     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.2.177     Document Type: Article

References (41)

1. Wiener J, Loud AV, Giacomelli F, Anversa P. Morphometric analysis of hypertension-induced hypertrophy of rat thoracic aorta. Am J Pathol. 1977;88:619-634.
2. Owens GK, Rabinovitch PS, Schwartz SM. Smooth muscle cell hypertrophy versus hyperplasia in hypertension. Proc Natl Acad Sci U S A. 1981;78:7759-7763.
3. Olivetti G, Melissari M, Marchetti G, Anversa P. Quantitative structural changes of the rat thoracic aorta in early spontaneous hypertension. Circ Res. 1982;51:19-26.
4. Lee RMKW, Garfield RE, Forrest JB, Daniel EE. Morphometric study of structural changes in the mesenteric blood vessels of spontaneously hypertensive rats. Blood Vessels. 1983;20:57-71.
5. Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in spontaneously hypertensive rat: role in cellular hypertrophy, hyperploidy and hyperplasia. Circ Res. 1982;51:280-289.
6. Owens GK, Reidy MA. Hyperplastic growth response of vascular smooth muscle cells following induction of acute hypertension in rats by aortic coarctation. Circ Res. 1985;57:695-705.
7. Chobanian AV. The arterial smooth muscle cell in systemic hypertension. Am J Cardiol. 1987;60:94I-98I.
8. Owens GK, Schwartz SM. Vascular smooth muscle cell hypertrophy and hyperploidy in Goldblatt hypertensive rat. Circ Res. 1983;53: 491-501.
9. Black MJ, Campbell JH, Campbell GR. Does smooth muscle cell polyploidy occur in resistance vessels of spontaneously hypertensive rats? Blood Vessels. 1988;25:89-100.
10. Black MJ, Dilley RJ, Bobik A. Renin-dependent hypertension induces smooth muscle polyploidy in large and small vessels. J Hypertens. 1993;11(suppl 5):S118-S119.
11. Schwartz S, Campbell G, Campbell J. Replication in smooth muscle cells in vascular disease. Circ Res. 1986;58:427-444.
12. Hamada M, Nishio I, Baba A, Fukuda K, Takeda J, Ura M, Hano T, Kuchii M, Masayama Y. Enhanced DNA synthesis of cultured vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis. 1990;81:191-198.
13. Hadrava V, Kruppa U, Russo RC, Lacourcière Y, Tremblay J, Hamet P. Vascular smooth muscle cell proliferation and its therapeutic modulation in hypertension. Am Heart J. 1991;122:1198-1203.
14. Owens GK. Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat. Circ Res. 1985;56: 525-536.
15. Owens GK. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension. 1987;9:178-187.
16. Black MJ, Adams MA, Bobik A, Campbell JH, Campbell GR. Effect of enalapril on aortic smooth muscle cell polyploidy in the spontaneously hypertensive rat. J Hypertens. 1989;7:997-1003.
17. Leitschuh AH, Chobanian AV. Inhibition of nuclear polyploidy by propranolol in aortic smooth muscle cells of hypertensive rats. Hypertension. 1987;9(suppl III):III-106-III-109.
18. Chobanian AV, Lichtenstein AH, Schwartz JH, Hanspal J, Brecher P. Effects of deoxycorticosterone/salt hypertension on cell ploidy in rat aortic smooth muscle cells. Circulation. 1987;75(suppl I): I-102-I-106.
19. Spagnoli LG, Orlandi A, Marino B, Mauriello A, De Angelis C, Ramacci MT. Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits. Atherosclerosis. 1995;114:29-44.
20. Hulsman WC. Biochemical profile of propionyl-L-carnitine. Cardiovasc Drugs Ther. 1991;5(suppl 1):7-10.
21. Paulson DJ, Traxler J, Schmidt M, Noonam J, Shug AL. Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation. Cardiovasc Res. 1986; 20:536-541.
22. Ferrari R, Giammatteo D, Agnoletti G, Cargnoni A, Ceconi C, Albertini A. Effect of L-carnitine derivatives on heart mitochondrial damage induced by lipid peroxidation. Pharmacol Res Commun. 1988;20:125-132.
23. Ferrari R, Ceconi C, Cargnoni A, Pasini E, Boffa GM, Curello S, Visioli O. The effect of propionyl-L-camitine on the ischemic and reperfused intact myocardium and their derived mitochondria. Cardiovasc Drugs Ther. 1991;5(suppl 1):57-66.
24. Bevilacqua M, Vago T, Norbiato G. Effect of propionyl-L-carnitine on L-type calcium channel in human heart sarcolemma. Cardiovasc Drues Ther. 1991;5(suppl 1):31-36.
25. Van Hinsbergh VWM, Scheffer MA. Effect of propionyl-L-carnitine on human endothelial cells. Cardiovasc Drugs Ther. 1991;5(suppl 1):97-106.
26. Manni E, Mancinelli R, Mingrone G, Recanicchi C. Effect of propionyl-L-carnitine, acetyl-L-carnitine and L-carnitine on isolated rat aorta. In: Proceeding of the Meeting, Focus on Propionyl-L-Carnitine Rome, Italy: October 23-25, 1989:18. Abstract.
27. Mikel UV, Fishbein WN, Bahr GF. Some practical considerations in quantitative absorbance microspectrophotometry. Anal Quant Cytol Histol. 1985;7:107-118.
28. Lee RMKW, Conyers RB, Kwan CY. Incidence of multinucleated and polyploid aortic smooth muscle cells cultured from different age groups of spontaneously hypertensive rats. Can J Physiol Pnarmacol. 1992;70:1496-1501.
29. Weibel ER. Stereological Methods, Volume 1: Practical Methods for Biological Morphometry. London, UK: Academic Press; 1979:26-30.
30. Mies C, Houldsworth J, Chaganti RSK. Extraction of DNA from paraffin blocks for southern blot analysis. Am J Surg Pathol. 1991; 15:169-174.
31. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989:E.3-5.
32. Lombardi DM, Owens GK, Schwartz SM. Ploidy in mesenteric vessels of aged spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 1989;13:475-479.
33. Dzau VJ, Gibbons GH. Cell biology of vascular hypertrophy in systemic hypertension. Am J Cardiol. 1988;62:30G-35G.
34. Owens GK. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am J Physiol. 1989;257:H1755-H1765.
35. Nillson J, Sjolund M, Palmberg L, Von Euler AM, Jonzon B, Thyberg J. The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation. Atherosclerosis. 1985;58:109-122.
36. Berridge MJ, Heslop JP, Irvine RF, Brown KD. Inositol triphosphate formation and calcium mobilization in Swiss 3T3 cells in response to platelet-derived growth factor. Biochem J. 1984;222:195-201.
37. Moolenaar WH, Aerts RJ, Tertoolen LGJ, De laat SW. The epidermal growth factor-induced calcium signal in A431 cells. J Biol Chem. 1986;261:279-284.
38. Chafouleas JG, Lagace L, Bolton WE, Boyd AE, Means AR. Changes in calmodulin and its mRNA accompany re-entry of quiescent (G0) cells into the cell cycle. Cell. 1984;36:73-81.
39. Noon JP, Rice PJ, Baldessarini RJ. Calcium leakage as a cause of the high resting tension in vascular muscle from the spontaneously hypertensive rat. Proc Natl Acad Sci U S A. 1978;75:1605-1607.
40. Huang SL, Wen YI, Kupranycz DB, Pang SC, Schlager G, Hamet P, Tremblay J. Abnormality of calmodulin in hypertension: evidence of the presence of an activator. J Clin Invest. 1988;82:276-281.
41. Greenberg ME, Ziff EB. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 1984;311:433-437.